NCT00601016View on ClinicalTrials.gov

A Phase II Study of Imiquimod 5 % Cream for the Treatment of Hemangioma in Infancy

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

September 30, 2006

Study Completion Date

September 30, 2006

Conditions
Hemangioma, Capillary
Interventions
DRUG

Imiquimod 5% cream

Imiquimod 5% cream applied topical on hemangioma once a day , 3 to 7 times a week for a maximum of 4 months.

Trial Locations (1)

H3T 1C5

Sainte-Justine Hospital University Center (CHU), Montreal

Sponsors
All Listed Sponsors
collaborator

Graceway Pharmaceuticals, LLC

INDUSTRY

lead

St. Justine's Hospital

OTHER